Weekly Roundup for March 27, 2026: Recent Publications in Women’s Mental Health
Learn more about the impact of perinatal depression on child neurodevelopment, new rapid-acting treatments for PPD, and new data reshaping how we treat menopausal symptoms.
Topiramate and Risk of Major Malformations: What Clinicians and Patients Need to Know
Topiramate exposure in early pregnancy is linked to higher rates of major malformations and more specifically to increased risk of oral clefts, with risk rising at higher doses.
Is There a Link Between Endometriosis and Perinatal Depression?
Emerging data suggest women with endometriosis face a higher risk of postpartum depression and anxiety, underscoring the need for proactive screening and individualized care.
Beyond the EPDS: Using AI to Identify Women at Risk for Postpartum Depression
AI and machine learning models, using tools like the EPDS and data from the electronic health record, may help clinicians detect and even prevent postpartum depression.
Can Esketamine Be Used to Prevent Postpartum Depression?
Emerging evidence suggests perioperative esketamine may reduce postpartum depression risk and improve recovery; however, information regarding long-term efficacy and optimal use is limited.
Weekly Roundup for March 13, 2026: Recent Publications in Women’s Mental Health
This week’s list spans antidepressant safety, benefits of psychotropic medication continuation on postpartum self-harm risk, anti-seizure medications and congenital malformations, and new approaches to PPD screening.